Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Inadequate bowel preparation before colonoscopy has a 20-30% rate and impedes on the quality of the procedure. The aim of this study was to develop a predictive score of inadequate bowel preparation, using a patient questionnaire on potential risk factors.

Methods: In this single center study, consecutive patients with colonoscopy indication were enrolled. The primary outcome was inadequate bowel preparation defined by Boston Bowel Preparation Scale (BBPS) score <7 or a score ≤1 in any of the 3 colonic segments.

Results: A total of 561 patients were included. Inadequate bowel preparation was seen in 25.0% of cases. Seven risk factors were selected into the prediction model of inadequate bowel preparation: diabetes or obesity, irregular physical activity, cirrhosis, use of antidepressants or neuroleptics, use of opiate medication, history of surgery and history of inadequate bowel preparation. The risk score, named PREPA-CO, had an AUROC of 0.621, adequately predicted bowel cleanliness in 68.3% of cases, with a specificity of 75.8% and a negative predictive value of 80.8%.

Conclusion: We developed a predictive score named "Prepa-Co", allowing the identification of patients at high risk of inadequate bowel preparation. In clinical practice, this score could help tailor the prescription of the preparation to the patient.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2021.101693DOI Listing

Publication Analysis

Top Keywords

bowel preparation
20
inadequate bowel
16
predictive score
8
score inadequate
8
bowel
5
preparation
5
inadequate
4
preparation based
4
based self-administered
4
self-administered questionnaire
4

Similar Publications

This study aimed to assess the impact of yeast beta-1,3/1,6-glucans (BG) on apparent digestibility coefficients (ADC) of nutrients, intestinal fermentative metabolites, fecal microbiota profile, and immune and antioxidant variables in puppies before and after surgical challenge. Two treatments were evaluated: control, without, and test, with oral supplementation of 65 mg/kg body weight/day of purified BG from Saccharomyces cerevisiae for 120 days. For this, 16 growing Beagle dogs were distributed in a completely randomized design (n = 8/treatment).

View Article and Find Full Text PDF

Vedolizumab Achieves Pan-Enteric Mucosal Healing in Crohn's Disease: A Prospective Observational Study.

United European Gastroenterol J

September 2025

Sheba Medical Center Tel Hashomer, Faculty of Medical and Health Sciences, Gastroenterology Institute, Tel-Aviv University, Tel Aviv, Israel.

Background: Mucosal healing (MH) is a key treatment goal in Crohn's disease (CD). However, evidence on pan-enteric MH (PE-MH) in CD patients treated with vedolizumab remains limited. We aimed to assess vedolizumab efficacy in achieving PE-MH using PillCam Crohn's capsule.

View Article and Find Full Text PDF

Background: Bowel preparation is essential for colonoscopy but may deter patients. Although low-volume laxatives are better tolerated, their impact on patient-reported outcomes remains unclear. We compared low- and intermediate volume bowel preparation and assessed the impact on tolerability, health-related quality of life (HRQoL) and work.

View Article and Find Full Text PDF

Objectives: We aimed to perform a multifactorial carbon footprint assessment and sensitivity analysis of the colonoscopy procedure.

Design: One-week single-center prospective study with all outpatients' diagnostic colonoscopies was realized (n=66). A cradle-to-grave life cycle assessment (LCA) methodology evaluated all essential supplies (accessories from 1 to 15), endoscopic procedure (energy consumption, CO2 insufflation, bowel preparation, and sedation), staff and patients transport and waste management.

View Article and Find Full Text PDF